[1] Blum A.HMG-CoA reductase inhibitors (statins),inflammation,and endothelial progenitor cells-New mechanistic insights of atherosclerosis[J].Biofactors,2014,40(3):295-302.[2] Ludman A,Venugopal V,Yellon DM,et al.Statins and cardioprotection——more than just lipid lowering[J].Pharmacol Ther,2009,122(1):30-43.[3] Tadasuke C,Seigo S,Kenji S,et al.Effect of a hydrophilic and a hydrophobic statin on cardiac salvage after ST-elevated acute myocardial infarction-a pilot study[J].Atherosclerosis,2014,237(1):251-258.[4] Moon GJ,Kim SJ,Cho YH,et al.Antioxidant effects of statins in patients with atherosclerotic cerebrovascular Disease[J].J Clin Neurol,2014,10(2):140-147.[5] Eirik I,Jonny H,Silvia R,et al.Rosuvastatin improves endothelial function in patients with inflammatory joint diseases,longitudinal associations with atherosclerosis and arteriosclerosis:results from the RORA-AS statin intervention study[J].Arthritis Res Ther,2015,17(1):279-282.[6] Jonathan EF,Jessica LF,Annapoorna SK.Statins,atherosclerosis regression and HDL:Insights from within the plaque[J].Int J Cardiol,2015,289(1):168-171.[7] Amemiya K,Yokoi H,Domei T,et al.Suppressive effects of standard-dose rosuvastatin therapy on the progression of coronary atherosclerosis in Japanese patients:the APOLLO study[J].J Atherosc Thromb,2014,21(12):1298-1307.[8] Tietge UJ.Hyperlipidemia and cardiovascular disease:inflammation,dyslipidemia,and atherosclerosis[J].Curr Opin Lipidol,2014,25(1):94-95.[9] 刘俊田.动脉粥样硬化发病的炎症机制的研究进展[J].西安交通大学学报:医学版,2015,36(2):141-152.[10] 王晓华,付超,张鑫,等.SDF-1/CXCR-4-R7轴与动脉粥样硬化关系研究进展[J].中国实验诊断学,2015,19(5):860-864.[11] Luigi GS,Elena B,Giuseppe S,et al.Role of inflammation in atherosclerosis[J].J Nucl Med,2007,48(1):800-815.[12] 常萍,郭瑞臣.心血管系统临床药理学[M].北京:化学工业出版社,2010:76-78.[13] Hatters DM,Peters-Libeu CA,Weisgraber KH.Apolipoprotein E structure:insights into function[J].Trends Biochem Sci,2006,31(8):445-454.[14] Dzimiri N,Meyer BF,Hussain SS,et al.Relevance of apolipoprotein E polymorphism for coronary artery disease in the Saudi population[J].Arch Pathol Lab Med,1999,123(12):1241-1245.[15] Sipahi I,Tuzcu EM,Schoenhagen P,et al.Paradoxical increase in lumen size during progression of coronary atherosclosis:observations from the REVERSAL trial[J].Atherosclerosis,2006,189(1):229-235.[16] Nissen SE,Nicholls SJ,Sipahi I,et al.Effect of very high-intensity statin therapy on regression of coronary atherosclerosis:the ASTEROID trial[J].JAMA,2006,295(13):1556-1565. |